MICHELLE KLEINMANN: Open Payments
NPI 1033562822 · WEST CHESTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,784 in 95 payments from 11 companies in 2025. Trend: 2023 $1,157 · 2024 $1,464 · 2025 $1,784
Food & beverage: $1,784
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $305 |
| ABBVIE INC. | 25 | $264 |
| Lilly USA, LLC | 9 | $255 |
| Axsome Therapeutics, Inc. | 7 | $218 |
| Vanda Pharmaceuticals Inc. | 10 | $203 |
| Novo Nordisk Inc | 10 | $149 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| Lundbeck LLC | 5 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Alkermes, Inc. | 3 | $56 |
Products named: REXULTI, VRAYLAR, Auvelity, HETLIOZ, INVEGA SUSTENNA, ABILIFY ASIMTUFII, MOUNJARO, CAPLYTA.
Industry payments across OH — which companies pay providers there.
